Target intelligence / Profile preview

U6 small nuclear RNA 627, pseudogene (RNU6-627P)

Target: RNU6-627P
Molecular classification: Other (noncoding RNA pseudogene)

Overview

RNU6-627P encodes a pseudogene sequence related to U6 small nuclear RNA (snRNA). U6 snRNA is a core component of the spliceosome, the complex responsible for removing introns from pre-mRNA in eukaryotes[3]. The U6 gene is highly conserved as it is essential for splicing activity[1][3], but many pseudogene copies such as RNU6-627P exist in the human genome and other vertebrates. These pseudogenes are non-functional: they are often not transcribed or, if transcribed, do not play a direct role in mRNA splicing or cellular regulation. While some pseudogenes can act as competitive endogenous RNAs (ceRNAs) or miRNA sponges, modifying gene expression[2], there is no evidence that RNU6-627P has such a function. RNU6-627P is a noncoding RNA pseudogene derived from the U6 snRNA gene. It is not a functional molecule and is not considered a direct therapeutic or pharmacological target. No biological, disease, or pharmacological roles are documented for RNU6-627P.

Other names: RNU6-627PRNA, U6 small nuclear 627, pseudogene

Mechanism of action

Not applicable; no drugs are described that act on this pseudogene.

Biological functions

None established; pseudogenes generally do not produce functional RNA or protein. The U6 small nuclear RNA plays a key role in pre-mRNA splicing[1][3], but the pseudogene derivative does not retain this function.

Disease associations

None specific. While some pseudogenes can influence gene regulation by acting as miRNA decoys or through other mechanisms[2], there is no literature support for RNU6-627P acting in disease.

Safety considerations

None known; not a therapeutic target.

Interacting drugs

None reported.

Biomarkers

None; pseudogene markers can be reported in some cases where noncoding RNAs are used for patient stratification, but RNU6-627P is not documented as a biomarker.

Beyond the preview

Go deeper on U6 small nuclear RNA 627, pseudogene (RNU6-627P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 627, pseudogene (RNU6-627P).

Explore the full profile